GlassScriptPhysician profile
Monica Thompson
NPI 1174158539
$1,089.76
in general payments reported to CMS, 2019-2025
16 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $284 · 2024: $510 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $990 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.81 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $209.49 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $195.18 | 2023-2025 | |
| Incyte Corporation | $124.24 | 2024 | Jakafi |
| Adc Therapeutics America, INC. | $110.96 | 2023 | |
| Merck Sharp & Dohme LLC | $74.56 | 2023-2025 | Keytruda |
| Astrazeneca Pharmaceuticals LP | $60.90 | 2024 | Enhertu |
| Janssen Biotech, INC. | $58.59 | 2024 | Akeega, Erleada, Darzalex |
| Daiichi Sankyo INC. | $56.61 | 2024-2025 | Enhertu |
| Iovance Biotherapeutics, INC. | $35.54 | 2025 | Amtagvi |
| Beigene USA, INC. | $33.12 | 2023 | Brukinsa |
| Genentech USA, INC. | $28.99 | 2024 | Tecentriq |
| Array Biopharma INC | $21.63 | 2025 | Mektovi, Tukysa, Braftovi |
| Puma Biotechnology, INC. | $20.95 | 2024 | |
| Tersera Therapeutics LLC | $20.68 | 2023 | Zoladex |
| Pfizer INC. | $20.35 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $17.97 | 2024 | Givlaari |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monica Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.